Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
The Ben May Department for Cancer Research, The University of Chicago, 929 East 57th Street, CIS W325F, Chicago, IL 60637, USA
Received 15 August 2008; received in revised form 1 October 2008; accepted 2 October 2008. published online 03 November 2008.
PII: S0304-3835(08)00811-2
doi:10.1016/j.canlet.2008.10.001
© 2008 Elsevier Ireland Ltd. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.